What happened
AstraZeneca disclosed that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors Update (2026-09-21): STAT+: Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial. The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study. Update (2026-09-23): STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more. As of next month, a loophole that allows Americans to personally import their medications by mail is closing Update (2026-10-27): STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more. A U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs